Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BPMC will rise by +0.62% over the next 2 Weeks and hit $130.27 by Thursday, July 31, 2025. In that time frame, BPMC's share price is expected to range between $123.65 and $136.29.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 31, 2025 | 123.68 | 130.12 | 136.08 |
| Jul 30, 2025 | 123.36 | 129.35 | 135.29 |
| Jul 29, 2025 | 124.53 | 130.29 | 136.18 |
| Jul 28, 2025 | 125.79 | 131.69 | 138.04 |
| Jul 25, 2025 | 122.14 | 127.71 | 133.52 |
| Jul 24, 2025 | 124.02 | 129.83 | 135.56 |
| Jul 23, 2025 | 123.55 | 129.07 | 134.60 |
| Jul 22, 2025 | 124.16 | 130.00 | 136.06 |
| Jul 21, 2025 | 125.58 | 131.41 | 136.75 |
| Jul 18, 2025 | 121.99 | 127.43 | 132.79 |
BPMC shares rose +0.14% in Friday, July 18, 2025's trading session, rising from a previous close of $129.28 to move at $129.46. The stock demonstrated notable intraday movement (see BPMC's key stats for a full breakdown), fluctuating between $129.46 and $129.46, a 0 trading range. While recent weeks have seen some volatility, BPMC has managed to secure a +0.86% gain over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 2.93M shares changing hands, 22.34M fewer than the previous session. This amounted to $379.54M in total market activity.
Will BPMC Continue Its Upward Trend?
According to analyst ratings and projections for BPMC, Blueprint Medicines Corporation shares are anticipated to increase by +4.87%, potentially reaching $136.08 per share by July 31, 2025. Short-term technical indicators currently suggest a neutral sentiment for BPMC. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the BPMC stock forecast, now is a good time to buy BPMC stock because its current trading price is -0.51% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on BPMC covering social and institutional perspectives.
BPMC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BPMC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 73.17% to 80.54%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 63.35%, suggests strong medium-term momentum. However, the 100-day RSI, at 57.97%, maintains a neutral outlook for the long term. Insights into BPMC's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Blueprint Medicines Corporation Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, Blueprint Medicines Corporation (BPMC) is positioned to show a strong performance in July 2025. The price is predicted to move between $105.81 and $118.09, settling at an average of $111.83. This could translate to a -13.62% loss.
August 2025
Based on current market signals, Blueprint Medicines Corporation is projected to trend august 2025. We forecast a trading range from $105.32 to $118.55, with a likely average price of $111.91. Investors could expect a potential return of -13.56%.
September 2025
Our predictive algorithms indicate Blueprint Medicines Corporation stock may see a shift in September 2025. The expected range spans $102.75–$116.87, with an average target of $110.10. This represents a cautious outlook and a possible loss of -14.95%.
October 2025
Analyzing established trends, Blueprint Medicines Corporation looks set to move in October 2025. Projections place the stock between $102.59 and $120.91, averaging around $113.61. This suggests a -12.24% loss from current levels.
November 2025
Market indicators suggest Blueprint Medicines Corporation could experience notable changes during November 2025. Prices could fluctuate within $109.05 to $128.29, with a midpoint forecast of $119.19. The stock might deliver a -7.93% loss.
December 2025
Forecasting for December 2025, models estimate that Blueprint Medicines Corporation may undergo key fluctuations. If trends hold, the stock might trade between $113.91 and $127.96, averaging $121.01. This signals a cautious trajectory with potential returns around -6.53%.
January 2026
According to our latest forecast models, Blueprint Medicines Corporation (BPMC) is positioned to show a strong performance in January 2026. The price is predicted to move between $113.65 and $127.18, settling at an average of $120.56. This could translate to a -6.87% loss.
February 2026
Based on current market signals, Blueprint Medicines Corporation is projected to trend february 2026. We forecast a trading range from $111.64 to $125.54, with a likely average price of $118.70. Investors could expect a potential return of -8.31%.
March 2026
Our predictive algorithms indicate Blueprint Medicines Corporation stock may see a shift in March 2026. The expected range spans $116.22–$129.89, with an average target of $122.85. This represents a cautious outlook and a possible loss of -5.11%.
April 2026
Analyzing established trends, Blueprint Medicines Corporation looks set to move in April 2026. Projections place the stock between $117.99 and $137.41, averaging around $128.05. This suggests a -1.09% loss from current levels.
May 2026
Market indicators suggest Blueprint Medicines Corporation could experience notable changes during May 2026. Prices could fluctuate within $122.66 to $137.50, with a midpoint forecast of $129.76. The stock might deliver a +0.23% gain.
June 2026
Forecasting for June 2026, models estimate that Blueprint Medicines Corporation may undergo key fluctuations. If trends hold, the stock might trade between $122.93 and $136.42, averaging $129.36. This signals a cautious trajectory with potential returns around -0.08%.
July 2026
According to our latest forecast models, Blueprint Medicines Corporation (BPMC) is positioned to show a strong performance in July 2026. The price is predicted to move between $120.73 and $134.71, settling at an average of $127.69. This could translate to a -1.37% loss.
BPMC's history of dividends and stock splits also plays a role in long-term investor confidence.

